340 related articles for article (PubMed ID: 21772815)
1. Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor.
Collins-Praino LE; Paul NE; Rychalsky KL; Hinman JR; Chrobak JJ; Senatus PB; Salamone JD
Front Syst Neurosci; 2011; 5():49. PubMed ID: 21772815
[TBL] [Abstract][Full Text] [Related]
2. Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism.
Podurgiel SJ; Spencer T; Kovner R; Baqi Y; Müller CE; Correa M; Salamone JD
Pharmacol Biochem Behav; 2016 Jan; 140():62-7. PubMed ID: 26459156
[TBL] [Abstract][Full Text] [Related]
3. Subthalamic and Cortical Local Field Potentials Associated with Pilocarpine-Induced Oral Tremor in the Rat.
Long LL; Podurgiel SJ; Haque AF; Errante EL; Chrobak JJ; Salamone JD
Front Behav Neurosci; 2016; 10():123. PubMed ID: 27378874
[TBL] [Abstract][Full Text] [Related]
4. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
Podurgiel SJ; Nunes EJ; Yohn SE; Barber J; Thompson A; Milligan M; Lee CA; López-Cruz L; Pardo M; Valverde O; Lendent C; Baqi Y; Müller CE; Correa M; Salamone JD
Neuroscience; 2013 Oct; 250():507-19. PubMed ID: 23867769
[TBL] [Abstract][Full Text] [Related]
5. Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor.
Salamone JD; Collins-Praino LE; Pardo M; Podurgiel SJ; Baqi Y; Müller CE; Schwarzschild MA; Correa M
Eur Neuropsychopharmacol; 2013 Aug; 23(8):972-7. PubMed ID: 22947264
[TBL] [Abstract][Full Text] [Related]
6. Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents implications for cholinergic involvement in parkinsonism.
Salamone JD; Correa M; Carlson BB; Wisniecki A; Mayorga AJ; Nisenbaum E; Nisenbaum L; Felder C
Life Sci; 2001 Apr; 68(22-23):2579-84. PubMed ID: 11392629
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of adenosine antagonists in two models of parkinsonian tremor.
Trevitt J; Kawa K; Jalali A; Larsen C
Pharmacol Biochem Behav; 2009 Nov; 94(1):24-9. PubMed ID: 19602422
[TBL] [Abstract][Full Text] [Related]
8. Blockade of adenosine A
Kosmowska B; Ossowska K; Wardas J
Behav Brain Res; 2022 Jan; 417():113585. PubMed ID: 34536428
[TBL] [Abstract][Full Text] [Related]
9. Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism.
Collins-Praino LE; Paul NE; Ledgard F; Podurgiel SJ; Kovner R; Baqi Y; Müller CE; Senatus PB; Salamone JD
Eur J Neurosci; 2013 Jul; 38(1):2183-91. PubMed ID: 23600953
[TBL] [Abstract][Full Text] [Related]
10. Tremulous jaw movements in rats: a model of parkinsonian tremor.
Salamone JD; Mayorga AJ; Trevitt JT; Cousins MS; Conlan A; Nawab A
Prog Neurobiol; 1998 Dec; 56(6):591-611. PubMed ID: 9871939
[TBL] [Abstract][Full Text] [Related]
11. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.
Betz AJ; Vontell R; Valenta J; Worden L; Sink KS; Font L; Correa M; Sager TN; Salamone JD
Neuroscience; 2009 Sep; 163(1):97-108. PubMed ID: 19467297
[TBL] [Abstract][Full Text] [Related]
12. Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor.
Podurgiel S; Collins-Praino LE; Yohn S; Randall PA; Roach A; Lobianco C; Salamone JD
Pharmacol Biochem Behav; 2013 Apr; 105():105-11. PubMed ID: 23360954
[TBL] [Abstract][Full Text] [Related]
13. The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine.
Podurgiel SJ; Yohn SE; Dortche K; Correa M; Salamone JD
Behav Brain Res; 2016 Feb; 298(Pt B):188-91. PubMed ID: 26590367
[TBL] [Abstract][Full Text] [Related]
14. Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243.
Salamone JD; Carlson BB; Rios C; Lentini E; Correa M; Wisniecki A; Betz A
Behav Brain Res; 2005 Jan; 156(2):173-9. PubMed ID: 15582103
[TBL] [Abstract][Full Text] [Related]
15. Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.
Collins LE; Paul NE; Abbas SF; Leser CE; Podurgiel SJ; Galtieri DJ; Chrobak JJ; Baqi Y; Müller CE; Salamone JD
Pharmacol Biochem Behav; 2011 Sep; 99(3):414-22. PubMed ID: 21640750
[TBL] [Abstract][Full Text] [Related]
16. Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.
Collins LE; Galtieri DJ; Brennum LT; Sager TN; Hockemeyer J; Müller CE; Hinman JR; Chrobak JJ; Salamone JD
Pharmacol Biochem Behav; 2010 Feb; 94(4):561-9. PubMed ID: 19958787
[TBL] [Abstract][Full Text] [Related]
17. Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism.
Salamone JD; Betz AJ; Ishiwari K; Felsted J; Madson L; Mirante B; Clark K; Font L; Korbey S; Sager TN; Hockemeyer J; Muller CE
Front Biosci; 2008 May; 13():3594-605. PubMed ID: 18508458
[TBL] [Abstract][Full Text] [Related]
18. The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism.
Correa M; Wisniecki A; Betz A; Dobson DR; O'Neill MF; O'Neill MJ; Salamone JD
Behav Brain Res; 2004 Jan; 148(1-2):47-54. PubMed ID: 14684247
[TBL] [Abstract][Full Text] [Related]
19. Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats.
Ishiwari K; Betz A; Weber S; Felsted J; Salamone JD
Pharmacol Biochem Behav; 2005 Feb; 80(2):351-62. PubMed ID: 15680188
[TBL] [Abstract][Full Text] [Related]
20. Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent.
Gandía J; Morató X; Stagljar I; Fernández-Dueñas V; Ciruela F
Behav Brain Res; 2015 Jul; 288():103-6. PubMed ID: 25862943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
